Summary of butyrophilin 1A1 staining results in tissue microarray scores for patients with different solid and hematological tumor types
| Primary site cancer immunohistochemistry/organ/anatomic site | Tumor tissue microarray # | Tumor Proportion Score scoring | ||
| ≥50% | 1–49% | ≤1% | ||
| Small cell lung cancer | AMSBIO 818c | 50% | 33% | 17% |
| Squamous non-small cell lung cancer | AMSBIO LC1921c | 84% | 10% | 6% |
| Adenocarcinoma non-small cell lung cancer | AMSBIO LC1912c | 45% | 20% | 35% |
| Colon cancer | AMSBIO CO802d | 40% | 20% | 40% |
| Ovarian cancer | TissueArray OV701a | 35% | 20% | 45% |
| Breast cancer | TissueArray BC8013d | 36% | 16% | 48% |
| Pancreatic cancer | AMSBIO PA804b | 30% | 18% | 52% |
| Bladder cancer | TissueArray BL481b | 32% | 10% | 58% |
| Head and neck cancer | TissueArray HN601d | 70% | 10% | 20% |
| Gastric cancer | TissueArray BS01012e | 20% | 10% | 70% |
| Esophageal squamous cell carcinoma | TissueArray BC02012a | 60% | 15% | 25% |